The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Mutation enrichment next-generation sequencing for quantitative detection of KRAS mutations in urine cell-free DNA from patients with advanced colorectal and other cancers.
 
Filip Janku
Consulting or Advisory Role - Deciphera; Foundation Medicine; Novartis; Sequenom; Trovagene
Research Funding - Agios; Astellas Pharma; Biocartis; BioMed Valley Discoveries; Deciphera; Foundation Medicine; Novartis; Roche; Trovagene
Other Relationship - Bio-Rad
 
Afsaneh Barzi
Consulting or Advisory Role - bioTheranostics; Merrion
 
Andrea Sartore-Bianchi
No Relationships to Disclose
 
Takeo Fujii
No Relationships to Disclose
 
Andrea Cassingena
No Relationships to Disclose
 
Giulia Siravegna
No Relationships to Disclose
 
Daniel D. Karp
No Relationships to Disclose
 
Sarina Anne Piha-Paul
No Relationships to Disclose
 
Vivek Subbiah
Patents, Royalties, Other Intellectual Property - Novartis, GSK, Nanocarrier, NorthWest Biotherapeutics, Roche/Genentech, BergPharma, Bayer, Incyte, FujiFilm, Pharmamar, D3, Pfizer Amgen, Abbvie, Multivir, BioXcel
 
Apostolia Maria Tsimberidou
Honoraria - Medfusion
Research Funding - Baxter (Inst); Bayer (Inst); EMD Serono (Inst); Foundation Medicine (Inst); ONYX (Inst)
 
Helen J. Huang
No Relationships to Disclose
 
Silvio Veronese
No Relationships to Disclose
 
Federica Di Nicolantonio
No Relationships to Disclose
 
Mark G. Erlander
Employment - Trovagene
Leadership - Trovagene
Stock and Other Ownership Interests - Trovagene
Consulting or Advisory Role - bioTheranostics
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Janssen; Merrimack; MolecularMatch; Oculose, LLC; Roche; Sanofi; Sirtex Medical; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Salvatore Siena
No Relationships to Disclose
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche
 
Alberto Bardelli
Stock and Other Ownership Interests - Horizon Discovery
Consulting or Advisory Role - Biocartis; Horizon Discovery; Trovagene
Speakers' Bureau - Novartis